EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combinatorial effects of a novel SHV-248 variant, NDM-5, and ompK35 deficiency drive high-level cefiderocol resistance in Klebsiella pneumoniae

Chuwen Zhao iD, Yuxuan Liu, Hanxu Hong iD, Yun Cao, Xinyue Dai, Qianbin Dai iD, DanDan Wei, Yang Liu

Microbiology Spectrum · 02.06.2026 · 14 (6)

DOI: 10.1128/spectrum.00026-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.06.2026. Verfasst von Chuwen Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: beta-Lactamases, Cefiderocol, Klebsiella pneumoniae, Porins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Nanchang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cefiderocol holds significant therapeutic value against metallo-β-lactamase-producing Enterobacterales. However, reduced susceptibility to cefiderocol in NDM-producing strains is increasingly observed. This study elucidated the mechanism of high-level cefiderocol resistance in a clinical Klebsiella pneumoniae strain (KP5663, ST147-KL64) producing NDM-5, which emerged without prior drug exposure. Whole-genome sequencing identified, alongside bla NDM-5 and ompK35 / ompK36 porin deficiencies, a novel β-lactamase gene variant, bla SHV-248 . Functional characterization revealed that SHV-248 exhibited a moderately higher affinity for cefiderocol (binding energy: −5.15 kcal/mol) and a 1.6-fold greater hydrolytic activity against nitrocefin compared to SHV-12. Consistent with this, heterologous expression of bla SHV-248 , but not bla SHV-12 , increased the cefiderocol minimum inhibitory concentration (MIC) by fourfold, although the MIC remained within the susceptible range. Critically, genetic complementation demonstrated that restoring functional ompK35 alone reduced the cefiderocol MIC of KP5663 by 16-fold, whereas complementation with ompK36 had no effect. These findings define a novel synergistic triad wherein the combined, rather than individual, action of bla NDM-5 , the novel variant bla SHV-248 , and porin deficiency (primarily ompK35 ) is necessary and sufficient for high-level cefiderocol resistance. IMPORTANCE This study identifies a novel SHV variant and, more importantly, delineates a distinct “key determinant combination” model for cefiderocol resistance. This model does not rely on exceptional enzyme overproduction but on the convergence of three clinically relevant factors: a transmissible bla NDM-5 , a chromosomally evolving SHV variant with incremental efficiency gains, and frequent porin loss. It underscores that, for NDM-producing Klebsiella pneumoniae , risk assessment must evolve to evaluate porin status alongside β-lactamase profiles, as even modestly more efficient enzymes like SHV-248 can become decisive factors within a permissive genetic background.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesCefiderocolKlebsiella pneumoniaePorinsbeta Lactam AntibioticsHumansBacterial ProteinsDrug Resistance, Multiple, BacterialKlebsiella InfectionsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Klebsiella pneumoniaeblaSHV-248carbapenem-resistantcefiderocolmetallo-β-lactamaseporin deficiencyresistance mechanism

Substanzen

Bacterial Proteinsbeta-LactamasesCefiderocolOmpK35 porin, Klebsiella pneumoniaeOmpK36 protein, Klebsiella pneumoniaePorinsbeta Lactam Antibiotics

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • First Clinical Medical College, Nanchang University, Nanchang, China.
  • School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Jiangxi Medical Center for Critical Public Health Events, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • China-Japan Friendship Jiangxi Hospital, National Regional Center for Respiratory Medicine, Nanchang, China.

ORCID-Profile: Chuwen Zhao, Hanxu Hong, Qianbin Dai

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangxi Province
  • Nanchang University

Zitieren

APA

Zhao, C., Liu, Y., Hong, H., Cao, Y., Dai, X., Dai, Q., Wei, D., & Liu, Y. (2026). Combinatorial effects of a novel SHV-248 variant, NDM-5, and ompK35 deficiency drive high-level cefiderocol resistance in Klebsiella pneumoniae. Microbiology Spectrum, 14(6). https://doi.org/10.1128/spectrum.00026-26

Vancouver

Zhao C, Liu Y, Hong H, Cao Y, Dai X, Dai Q, et al. Combinatorial effects of a novel SHV-248 variant, NDM-5, and ompK35 deficiency drive high-level cefiderocol resistance in Klebsiella pneumoniae. Microbiology Spectrum. 2026;14(6). doi:10.1128/spectrum.00026-26

BibTeX
@article{Zhao2026,
  author = {Zhao, Chuwen and Liu, Yuxuan and Hong, Hanxu and Cao, Yun and Dai, Xinyue and Dai, Qianbin and Wei, DanDan and Liu, Yang},
  title = {Combinatorial effects of a novel SHV-248 variant, NDM-5, and ompK35 deficiency drive high-level cefiderocol resistance in Klebsiella pneumoniae},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1128/spectrum.00026-26}
}
Kostenlos starten →